Skip Navigation

Diversion Quarterly Report, Q1 2024

The cover of the report titled "Diversion Quarterly Report, Q1 2024"

Diversion Quarterly Report, Q1 2024

Benchmarking your diversion data is crucial to understanding how your drug diversion program is performing. Bluesight’s Diversion Quarterly is a publicly available resource that provides a snapshot of the industry based on aggregated data from ControlCheck customers to help hospitals benchmark their efforts. Those same customers can then benchmark themselves against data from similar-sized hospitals without even leaving the application. 

Download the latest information about our suite of medication intelligence products by using the button below.

Want to read the rest?